In the present study, we did not include cases with SCN1A-related epileptic encephalopathies in the OXC group, so that the iatrogenic exacerbation of seizures and the subsequent outcome bias could be avoided. The gene discussed is SCN1A; the disease is Epileptic encephalopathy.